164
Participants
Start Date
May 19, 2021
Primary Completion Date
November 30, 2023
Study Completion Date
May 30, 2027
Molgramostim
Molgramostim 300 µg nebulizer solution
Placebo
Matching placebo nebulizer solution
Molgramostim Open-label
Molgramostim 300 µg nebulizer solution
Hôpital Erasme, Brussels
Royal Prince Alfred Hospital, Camperdown
Westmead Hospital, Westmead
UZ Leuven - Campus Gasthuisberg - Pneumologie, Leuven
Health Sciences University Gulhane Training and Research Hospital, Ankara
Attikon University Hospital, Athens
University of Pittsburgh, Pittsburgh
University of Pennsylvania Perelman School of Medicine - Pulmonology, Philadelphia
University of Maryland Medical Center, Baltimore
Fondazione IRCCS Policlinico San Matteo, Pavia
Wake Med Health & Hospital, Raleigh
Duke University Medical Center, Durham
Emory University, Atlanta
University of Florida Health, Gainesville
Yedikule Chest Disease and Surgery Training and Research Hospital, Istanbul
CHU Pontchaillou, Rennes
Ege University Hospital - Department of Pulmonology, Bornova
Cleveland Clinic, Cleveland
Ruhrlandklinik Westdeutsches Lungenzentrum, Essen
Loyola University, Maywood
Washington University in St. Louis, St Louis
Thoraxklinik Heidelberg gGmbH am Universitätsklinikum Heidelberg, Heidelberg
Hôpital Louis Pradel, Bron
University Of Arkansas For Medical Services, Little Rock
UT Southwestern Medical Center, Dallas
National Jewish Health, Denver
Asklepios Fachkliniken Muenchen-Gauting, Muenchen-Gauting
UCLA David Geffen School of Medicine, Los Angeles
Yale University, New Haven
Cincinnati Children's Hospital Medical Center, Cincinnati
University of Calgary, Calgary
St Joseph's Healthcare Hamilton Research, Hamilton
University Institute of Cardiology and Respirology of Quebec, Québec
St. Vincent's University Hospital, Dublin
Hokkaido University Hospital, Sapporo
Kanagawa Cardiovascular and Respiratory Center, Yokohama
Tohoku University Hospital - Respiratory Tract Medicine, Sendai
National Hospital Organization Kinki-Chuo Chest medical Center, Sakai
Kyorin University Hospital, Mitaka
Chiba University Hospital - Respiratory Medicine, Chiba
Kumamoto University Hospital, Kumamoto
Aichi Medical University Hospital, Nagakute
Saitama Red Cross Hospital, Saitama
St Antonius Hospital, Nieuwegein
Instytut Gruzlicy i Chorob Pluc, Warsaw
Hospital Pulido Valente, Lisbon
Hospital São João, Porto
"Institutul de Pneumoftiziologie Marius Nasta", Bucharest
Seoul National University Hospital, Seoul
Severance Hospital - Yonsei University Health System - Pulmonary, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Hospital Universitario de Bellvitge, Barcelona
Royal Brompton and Harefield NHS Foundation Trust, London
Savara Inc.
INDUSTRY